Alt Text: Retatrutide peptide regulatory status map showing investigational status, FDA approval limits, and compounding caution Full AI Image Prompt: Create a clean medical regulatory infographic titled Retatrutide Regulatory Status Map. Use a flowchart layout beginning with Retatrutide research and branching to Clinical trials, Not FDA-approved, Compounding caution, Unapproved products, and Clinician discussion. Include a final box labeled Evidence gaps remain. Use professional editorial styling, white background, calm blue and green accents, document and trial icons, no people, no product packaging, no vendor imagery, no buying guidance, and no language implying availability or approved use.
Talk to your healthcare provider about how to recognize and treat low blood sugar and check your blood sugar before you start and while you take Wegovy
This publication does not endorse, vouch for, audit, or accept responsibility for the accuracy, completeness, or fairness of customer reviews posted on any third-party platform, including but not limited to general-purpose review sites, social media platforms, and online discussion forums
Retatrutide Side Effects and Safety "Retatrutide side effects" appear similar to other GLP-1 receptor agonists, including gastrointestinal issues such as nausea and diarrhea
